167 related articles for article (PubMed ID: 25017797)
21. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
Daniel KG; Chen D; Orlu S; Cui QC; Miller FR; Dou QP
Breast Cancer Res; 2005; 7(6):R897-908. PubMed ID: 16280039
[TBL] [Abstract][Full Text] [Related]
22. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
Yang H; Shi G; Dou QP
Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity and computational modeling of ternary copper (II) complexes with 3-indolecarboxylic acid and 1,10-phenanthroline.
Zhang Z; Wang H; Wang Q; Yan M; Wang H; Bi C; Sun S; Fan Y
Int J Oncol; 2016 Aug; 49(2):691-9. PubMed ID: 27278680
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.
Chen D; Frezza M; Shakya R; Cui QC; Milacic V; Verani CN; Dou QP
Cancer Res; 2007 Oct; 67(19):9258-65. PubMed ID: 17909033
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
Chen X; Yang Q; Chen J; Zhang P; Huang Q; Zhang X; Yang L; Xu D; Zhao C; Wang X; Liu J
Cell Physiol Biochem; 2018; 49(2):780-797. PubMed ID: 30165348
[TBL] [Abstract][Full Text] [Related]
26. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors.
Halasi M; Wang M; Chavan TS; Gaponenko V; Hay N; Gartel AL
Biochem J; 2013 Sep; 454(2):201-8. PubMed ID: 23772801
[TBL] [Abstract][Full Text] [Related]
27. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
28. Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity.
Zhong YL; Xu GJ; Huang S; Zhao L; Zeng Y; Xiao XF; An JL; Liu J; Yang T
Eur J Pharmacol; 2019 Jun; 853():184-192. PubMed ID: 30928629
[TBL] [Abstract][Full Text] [Related]
29. Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.
Felth J; Lesiak-Mieczkowska K; D'Arcy P; Haglund C; Gullbo J; Larsson R; Linder S; Bohlin L; Fryknäs M; Rickardson L
Invest New Drugs; 2013 Jun; 31(3):587-98. PubMed ID: 23179339
[TBL] [Abstract][Full Text] [Related]
30. In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells.
Noolu B; Gogulothu R; Bhat M; Qadri SS; Reddy VS; Reddy GB; Ismail A
Anticancer Agents Med Chem; 2016; 16(12):1605-1614. PubMed ID: 27198988
[TBL] [Abstract][Full Text] [Related]
31. BU-32: a novel proteasome inhibitor for breast cancer.
Agyin JK; Santhamma B; Nair HB; Roy SS; Tekmal RR
Breast Cancer Res; 2009; 11(5):R74. PubMed ID: 19821999
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment.
Xu DC; Yang L; Zhang PQ; Yan D; Xue Q; Huang QT; Li XF; Hao YL; Tang DL; Ping Dou Q; Chen X; Liu JB
Acta Pharmacol Sin; 2022 Aug; 43(8):2128-2138. PubMed ID: 34893683
[TBL] [Abstract][Full Text] [Related]
33. Schiff base Cu(II) complexes as inhibitors of proteasome in human cancer cells.
Konarikova K; Frivaldska J; Gbelcova H; Sveda M; Ruml T; Janubova M; Zitnanova I
Bratisl Lek Listy; 2019; 120(9):646-649. PubMed ID: 31475547
[TBL] [Abstract][Full Text] [Related]
34. Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity.
Milacic V; Chen D; Giovagnini L; Diez A; Fregona D; Dou QP
Toxicol Appl Pharmacol; 2008 Aug; 231(1):24-33. PubMed ID: 18501397
[TBL] [Abstract][Full Text] [Related]
35. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
[TBL] [Abstract][Full Text] [Related]
36. Proteasome inhibitor inhibits proliferation and induces apoptosis in renal interstitial fibroblasts.
Zhu B; Jin Y; Han L; Chen H; Zhong F; Wang W; Chen N
Pharmacol Rep; 2013; 65(5):1357-65. PubMed ID: 24399732
[TBL] [Abstract][Full Text] [Related]
37. Metal complexes as inhibitors of the 26S proteasome in tumor cells.
Verani CN
J Inorg Biochem; 2012 Jan; 106(1):59-67. PubMed ID: 22112841
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.
Jorda R; Dušek J; Řezníčková E; Pauk K; Magar PP; Imramovský A; Kryštof V
Eur J Med Chem; 2017 Jul; 135():142-158. PubMed ID: 28441582
[TBL] [Abstract][Full Text] [Related]
39. Synthetic analogs of green tea polyphenols as proteasome inhibitors.
Smith DM; Wang Z; Kazi A; Li LH; Chan TH; Dou QP
Mol Med; 2002 Jul; 8(7):382-92. PubMed ID: 12393936
[TBL] [Abstract][Full Text] [Related]
40. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
